Effect of intraperitoneal administration of low-molecular-weight heparin on plasma tissue factor pathway inhibitor levels in CAPD patients

Nephron

Volumn 91, Issue 1, 2002, Pages 162-163

  Demirkan, Fatih ^a   Akarsu, Mesut ^a   Sifil, Aykut ^b   Tutucu, Kutlay Naci ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Division of Nephrology   (Turkey)

Author keywords

Continuous ambulatory peritoneal dialysis; Intraperitoneal low molecular weight heparin; Tissue factor pathway inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 10A; ENOKSIPARIN; LOW MOLECULAR WEIGHT HEPARIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; DRUG EFFECT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ANTICOAGULANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XA; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, INTRAPERITONEAL; LIPOPROTEINS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;

EID: 0036097723     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057620     Document Type: Article

References (5)

1. Long-term intraperitoneal application of low molecular weight heparin in a continuous ambulatory peritoneal dialysis patient with deep vein thrombosis
2. Heparin induced release of extrinsic coagulation pathway inhibitor (EPI)
3. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis
4. Tissue factor pathway inhibitor and tissue factor in HD and CAPD
5. Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis